Evaluating Drug Cost per Response with SGLT2 Inhibitors in Patients with Type 2 Diabetes Mellitus

nork Lopez, Janice M.S., Macomson, Brian, Ektare, Varun, Patel, Dipen, Botteman, Marc
Argitaratua izan da Am Health Drug Benefits (2015)

Clinical and economic analysis of outcomes of dose tapering or withdrawal of tumor necrosis factor-α inhibitors upon achieving stable disease activity in rheumatoid arthritis patie...

nork Aletaha, Daniel, Snedecor, Sonya J, Ektare, Varun, Xue, Mei, Bao, Yanjun, Garg, Vishvas
Argitaratua izan da Clinicoecon Outcomes Res (2017)